Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M53.2Revenue (TTM) $M4.8Net Margin (%)-26.8Altman Z-Score2.1
Enterprise Value $M50.6EPS (TTM) $--Operating Margin %-23.5Piotroski F-Score3
P/E(ttm)--Beneish M-Score-5.0Pre-tax Margin (%)-26.8Higher ROA y-yN
Price/Book11.010-y EBITDA Growth Rate %--Quick Ratio1.1Cash flow > EarningsY
Price/Sales11.75-y EBITDA Growth Rate %--Current Ratio1.1Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-178.6ROA % (ttm)-14.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-26.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M64.7ROIC % (ttm)-26.1Gross Margin Increase y-yY

Gurus Latest Trades with IGXT

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

IGXT is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


IGXT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Boudreau BernardDirector 2016-11-30Sell25,000$0.7512view
Durham John EdwardVP Manufacturing 2016-10-07Buy3,000$0.7610.53view
Durham John EdwardVP Manufacturing 2016-09-21Buy10,000$0.831.2view
Godin AndreEVP & CFO 2016-09-14Buy20,000$0.7216.67view
Boudreau BernardDirector 2016-01-22Buy65,000$0.4971.43view
Bechard Robert J.VP Corporate Development 2016-01-22Buy10,000$0.568view
Godin AndreEVP + CFO 2016-01-20Buy20,000$0.4110view
Godin AndreEVP & CFO 2015-12-30Buy9,500$0.5261.54view
Godin AndreEVP + CFO 2015-12-23Buy15,350$0.5164.71view
Godin AndreEVP + CFO 2015-12-22Buy19,650$0.568view

Press Releases about IGXT :

Quarterly/Annual Reports about IGXT:

News about IGXT:

Articles On GuruFocus.com

More From Other Websites
INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events Jan 04 2017
IntelGenx Announces Definitive Agreement with Chemo Group for a Generic CNS Tablet Jan 04 2017
IntelGenx Announces Definitive Agreement with Chemo Group for a Generic CNS Tablet Jan 04 2017
IntelGenx Announces Development and Commercialization Agreement with Endo Ventures Dec 27 2016
INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events Dec 27 2016
IntelGenx Announces Development and Commercialization Agreement with Endo Ventures Dec 27 2016
INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events Dec 14 2016
RedHill Biopharma and IntelGenx Announce Definitive Agreement for Commercialization of RIZAPORT®... Dec 14 2016
RedHill Biopharma and IntelGenx Announce Definitive Agreement for Commercialization of RIZAPORT®... Dec 14 2016
IntelGenx and RedHill Biopharma Announce Definitive Agreement for Commercialization of RIZAPORT(R)... Dec 14 2016
INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events Dec 01 2016
IntelGenx Strengthens Partnership with Chemo Group by Signing a Co-Development Term Sheet for an... Dec 01 2016
IntelGenx Strengthens Partnership with Chemo Group by Signing a Co-Development Term Sheet for an... Dec 01 2016
IntelGenx Technologies Corp. :IGXT-US: Earnings Analysis: Q3, 2016 By the Numbers : November 29,... Nov 29 2016
IntelGenx Secures a License For Tadalafil Erectile Dysfunction Dosing Patent Nov 21 2016
INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events Nov 21 2016
IntelGenx Secures a License For Tadalafil Erectile Dysfunction Dosing Patent Nov 21 2016
INTELGENX TECHNOLOGIES CORP. Financials Nov 18 2016
IntelGenx Reports Profitable Third Quarter with Increased Growth in Revenues from Second Quarter Nov 10 2016
INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events Nov 10 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)